This article was originally published in RAJ Devices
Regulation bans dura mater and stipulates device reprocessing requirements
You may also be interested in...
Reports from Norway about deaths in very frail, elderly patients soon after receiving Pfizer/BioNTech’s COVID-19 jab have drawn regulatory scrutiny. Australia is looking at whether specific warnings about risks of vaccination in the very frail elderly or terminally ill should be included in the product information.
Viagra will soon be available OTC in Ireland following a successful switch, but patients will have to complete a mandatory consultation with a pharmacist before the ED treatment can be supplied.
Guidance on protecting participants in bioequivalence studies during the COVID-19 pandemic has been published by the FDA.